MARKETS
Analyst Actions

Guggenheim Initiates Coverage On MSG Rangers with Buy Rating, Announces Price Target of $278

Oct 28, 2026 · 09:28 AM ET· updated 9h ago

Guggenheim analyst Curry Baker initiates coverage on MSG Rangers (NYSE:MSGR) with a Buy rating and announces Price Target of $278.

Share
Why It Matters

A smart investing company thinks MSG Rangers stock looks good. This is just one person's opinion, not a guarantee of future results.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.